Prostatic Neoplasms: all 6,484 studies
Page 8 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSARecruitingNCT06600698Phase 1/2
- Working Out M0 Bipolar Androgen TherapyRecruitingNCT06594926Phase 2
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseRecruitingNCT06592924Phase 3
- Hypofractionated WPPT With HDR BoostRecruitingNCT06591819Phase 2
- Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate CancerRecruitingNCT06585007Phase 3
- Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate CancerRecruitingNCT06584279
- Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate CancerRecruitingNCT06582628Phase 2
- Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)RecruitingNCT06582446Phase 2
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate CancerRecruitingNCT06579911Not applicable
- ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate CancerRecruitingNCT06579417
- Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate CancerRecruitingNCT06575257Phase 2
- STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate CancerRecruitingNCT06574880Phase 1/2
- Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered ValidationNot yet recruitingNCT06573736
- A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerRecruitingNCT06568094Phase 1/2
- Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic ValidationRecruitingNCT06565247Phase 3
- Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialRecruitingNCT06563388Phase 3
- Veteran Peer Navigators to Promote Shared Decision Making for PSA ScreeningNot yet recruitingNCT06549036Not applicable
- Prostate Adaptive Radiation TherapyRecruitingNCT06547398Not applicable
- Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）Not yet recruitingNCT06546527Early Phase 1
- Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)RecruitingNCT06546267
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06545942Phase 1
- The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence RecoveryRecruitingNCT06543420Not applicable
- Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyRecruitingNCT06542757Not applicable
- Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black MenRecruitingNCT06541210Not applicable
- Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral MetastasisRecruitingNCT06536725
- Folate Study in Men With Advanced Prostate CancerNot yet recruitingNCT06536374Phase 2
- Precise Oncology Interventions in Nutrition and Training (OnPoint)RecruitingNCT06534918Not applicable
- Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line TreatmentRecruitingNCT06529549
- Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing DiseaseRecruitingNCT06526299Phase 2
- Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.Not yet recruitingNCT06524219
- Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.RecruitingNCT06523634Not applicable
- Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical ProstatectomyRecruitingNCT06521710Not applicable
- The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)RecruitingNCT06520345Phase 3
- Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate CancerRecruitingNCT06518226Not applicable
- Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate CancerRecruitingNCT06517901Not applicable
- Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate CancerRecruitingNCT06517719
- Technologies to Improve QoL of Prostate CancerNot yet recruitingNCT06516276Not applicable
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)RecruitingNCT06511141Not applicable
- Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan EraRecruitingNCT06508567Not applicable
- Safety and Efficacy of KLS-1 Monotherapy in Malignant NeoplasmsRecruitingNCT06506643Phase 1/2
- Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease StageEnrolling by invitationNCT06505356Not applicable
- FUS-TB VS COG-TB in Small Lesions of Prostate CancerNot yet recruitingNCT06504017Not applicable
- Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.Not yet recruitingNCT06500247Phase 2
- Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer SurvivorsRecruitingNCT06500169Not applicable
- Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)RecruitingNCT06496581Phase 3
- Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialRecruitingNCT06496256Not applicable
- 68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer RiskRecruitingNCT06494696
- Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)RecruitingNCT06491056
- Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialNot yet recruitingNCT06489496
- Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)RecruitingNCT06487507Not applicable
- PET/MRI to Stage Prostate Cancer PatientsRecruitingNCT06484361Phase 2
- Evaluation of Perilesional Biopsy in Diagnosis of Prostate CancerRecruitingNCT06482645Not applicable
- Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)RecruitingNCT06482489
- Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate CancerRecruitingNCT06480110Phase 1/2
- Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate CancerRecruitingNCT06474806Phase 2
- Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer PatientsRecruitingNCT06473259
- Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant MenEnrolling by invitationNCT06472817
- Prophylactic Prostatectomy for Prostate Cancer (PPPC)Enrolling by invitationNCT06470685
- Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the BodyRecruitingNCT06470243Phase 3
- A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa PatientsRecruitingNCT06469710
- Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate CancerRecruitingNCT06468332
- Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate CancerRecruitingNCT06468293Not applicable
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)RecruitingNCT06462963Not applicable
- Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT06462508Early Phase 1
- Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT06462495Early Phase 1
- Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)RecruitingNCT06461819Phase 2
- A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerRecruitingNCT06457919Phase 1/2
- Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer DetectionNot yet recruitingNCT06453785Not applicable
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsRecruitingNCT06451497Phase 1
- A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate CancerRecruitingNCT06451445Not applicable
- Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMARecruitingNCT06450548Not applicable
- Study of STM-416p Administered to Patients Undergoing Radical ProstatectomyRecruitingNCT06450106Phase 1
- 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate CancerRecruitingNCT06449781Phase 2
- Training for Men Undergoing Androgen Deprivation Therapy.RecruitingNCT06449664Not applicable
- The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate CancerRecruitingNCT06446401
- Multi-Modal Image Fusion for Precision Prostate Biopsy NavigationNot yet recruitingNCT06441292Not applicable
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsRecruitingNCT06440005Phase 1
- Contribution of the VERITON-CT Camera in Prostate Bone RadiostereotaxyNot yet recruitingNCT06439784Not applicable
- Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response GenesRecruitingNCT06439225Phase 3
- Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate CancerRecruitingNCT06437574Phase 2
- 68Ga-AAZTA-093 PET/CT: First-in-human StudyRecruitingNCT06437496Early Phase 1
- Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort StudyNot yet recruitingNCT06435702
- A Multi-center Investigation of Family Health.RecruitingNCT06433349
- Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA TreatmentRecruitingNCT06433063Not applicable
- Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyNot yet recruitingNCT06430411
- Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)RecruitingNCT06429813Not applicable
- Prostate Cancer Awareness and Initiative for Screening in the European UnionEnrolling by invitationNCT06424275
- Microbiome Molecular CharaterisationRecruitingNCT06423976
- Access to Genetic Testing in Underserved Patients With CancerRecruitingNCT06422455Not applicable
- Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?RecruitingNCT06420115Not applicable
- 99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate CancerRecruitingNCT06419348Early Phase 1
- The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer PatientsRecruitingNCT06406803Not applicable
- Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening AccuracyRecruitingNCT06402552Not applicable
- High Intensity Focused Ultrasound in Prostate CancerRecruitingNCT06402357Phase 2
- Clinical Trial of TB511 in Advanced Solid TumorsNot yet recruitingNCT06400160Phase 1/2
- Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate CancerRecruitingNCT06398639Not applicable
- Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)RecruitingNCT06398613Not applicable